These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8449204)

  • 21. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
    Pritchett EL; Schulte MC; Schnell D; Marcello SR; Wilkinson WE; Page RL; Connolly SJ;
    J Clin Pharmacol; 2002 Apr; 42(4):388-94. PubMed ID: 11936563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
    Pisapia A; Bine-Scheck F; Schenowitz A; Domerego JJ; Maraud L; Canler A; Labban N; Viart R; Aubry P; Beruben E
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Saito E; Kobayashi T; Okumura K
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
    Biffi M; Boriani G; Bronzetti G; Capucci A; Branzi A; Magnani B
    Heart; 1999 Aug; 82(2):176-82. PubMed ID: 10409531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis.
    Miyakoshi M; Ikeda T; Miwa Y; Sakaki K; Ishiguro H; Abe A; Tsukada T; Mera H; Yusu S; Yoshino H
    J Cardiol; 2009 Aug; 54(1):86-92. PubMed ID: 19632526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Sep; 77(9):595-9. PubMed ID: 3195178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
    Frances Y; Luccioni R; Delaage M; Donnarel G; Medvedowsky JL; Quiret JC
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term low-dose cibenzoline in patients with chronic renal failure undergoing hemodialysis.
    Honda T; Soejima H; Honda T
    Jpn Circ J; 2000 Jan; 64(1):72-5. PubMed ID: 10651210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous clofilium for conversion of atrial fibrillation.
    Borzak S; Al-Khaled N; Douthat L; Steinberg M; Goldberg AD
    Am J Cardiol; 1997 Jan; 79(1):94-7. PubMed ID: 9024749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
    Hermida JS; Mabo P; Rouesnel P; Scheck F; Canler A; Barthélémy M; Wanszelbaum H
    Ann Cardiol Angeiol (Paris); 1995 Jan; 44(1):49-55. PubMed ID: 7702357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery.
    Komatsu T; Tachibana H; Satoh Y; Ozawa M; Kunugita F; Tashiro A; Okabayashi H; Nakamura M
    Circ J; 2010 Sep; 74(9):1859-65. PubMed ID: 20631453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological properties in patients undergoing atrial compartment operation for chronic atrial fibrillation with mitral valve disease.
    Lo HM; Lin FY; Lin JL; Tseng CD; Hsu KL; Chiang FT; Tseng YZ
    Eur Heart J; 1997 Nov; 18(11):1805-15. PubMed ID: 9402456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of MgSO4 and glucose, insulin and potassium (GIK) on atrial conduction during the first 12 hours after DC-conversion of chronic atrial fibrillation.
    Ingemansson MP; Carlson J; Platonov P; Olsson SB
    Scand Cardiovasc J; 2001 Oct; 35(5):340-6. PubMed ID: 11771826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dog.
    Sassine A; Massé C; Dufour A; Hirsch JL; Cazes M; Puech P
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):201-18. PubMed ID: 6476979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of cibenzoline and flecainide administered via an intravenous route in reducing auricular arrhythmia].
    Metz D; Chapoutot L; Laudinat JM; Ehrhard V; Taupin JM; Chabert JP; Metivet F; Pollet E; Bajolet A
    Ann Cardiol Angeiol (Paris); 1990 Jan; 39(1):1-6. PubMed ID: 2107784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.